Skip to content
Screener

Bausch + Lomb BLCO Common Stock Shares Issued

Common Stock Shares Issued at other companies

HRO
HarrowHROW
37.5M+2.1%
Schering-Plough logo
Schering-PloughSGP
2.2M+0.3%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
43.3M+2.5%
Bausch Health Companies logo
Bausch Health CompaniesBHC
373.5M+1.1%
PBH
Prestige Consumer HealthcarePBH
56.3M+0.3%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO

Other financials

Income statement

See full
Revenue$1.4B+9.1%
Operating income$83.0M+855%
Net income-$14.0M+77.4%
EPS (diluted)-$0.04+77.8%

Balance sheet

See full
Cash & equivalents$378.0M+39.0%
Total debt$5.1B+2.4%
Total equity$6.4B-1.0%
Total assets$13.9B+0.2%

Cash flow

See full
Operating cash flow$153.0M+337%
CapEx$71.0M-20.2%
Free cash flow$82.0M+252%

Valuation

See full
Market cap$6.01B+24.5%
Enterprise value$10.71B+12.6%
P/S1.1×+0.1×

Profitability

See full
Operating margin6.1%+5.3pp
Net margin-3.2%-1.0pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-2.7%-0.7pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001860742-26-000088
Line itemJune 30, 2026December 31, 2025
Total liabilities7,4157,503
Commitments and contingencies (Note 16)
Equity
Common shares, no par value, unlimited shares authorized, 357,057,005 and 354,209,319 issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital8,6108,563
Accumulated deficit(1,016)(931)
Accumulated other comprehensive loss(1,218)(1,184)
Total Bausch + Lomb Corporation shareholders’ equity6,3766,448

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch + Lomb's common stock shares issued?
Bausch + Lomb (BLCO) reported common stock shares issued of 357.1M in Q2 2026.
How has Bausch + Lomb's common stock shares issued changed year-over-year?
Bausch + Lomb's common stock shares issued increased by 0.9% year-over-year, from 353.8M to 357.1M.
What is the long-term trend for Bausch + Lomb's common stock shares issued?
Over 4 years (2021 to 2025), Bausch + Lomb's common stock shares issued has grown at a 0.3% compound annual growth rate (CAGR), from 350M to 354.2M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Bausch + Lomb's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude